Lifecore Biomedical, Inc. (FRA:LDE)
6.55
+0.20 (3.15%)
At close: Dec 5, 2025
Lifecore Biomedical Revenue
In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $128.87M USD with 0.47% growth. Lifecore Biomedical had revenue of $31.11M in the quarter ending September 30, 2025, with 25.92% growth.
Revenue
$128.87M
Revenue Growth
+0.47%
P/S Ratio
2.16
Revenue / Employee
$317.41K
Employees
406
Market Cap
245.73M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 25, 2025 | 128.87M | 606.00K | 0.47% |
| May 26, 2024 | 128.26M | 24.99M | 24.20% |
| May 28, 2023 | 103.27M | -8.00M | -7.19% |
| May 29, 2022 | 111.27M | 10.40M | 10.31% |
| May 30, 2021 | 100.87M | -59.19M | -36.98% |
| May 31, 2020 | Pro | Pro | Pro |
| May 26, 2019 | Pro | Pro | Pro |
| May 27, 2018 | Pro | Pro | Pro |
| May 28, 2017 | Pro | Pro | Pro |
| May 29, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |
Lifecore Biomedical News
- 24 days ago - Lifecore Biomedical to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 26 days ago - Lifecore Biomedical: A Disconnect Between Share Price And Business Progress - Seeking Alpha
- 4 weeks ago - Lifecore Biomedical Inc (LFCR) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus
- 4 weeks ago - Q1 2026 Lifecore Biomedical Inc Earnings Call Transcript - GuruFocus
- 4 weeks ago - Lifecore Biomedical, Inc. (LFCR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Lifecore Biomedical, Inc. 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - Lifecore (LFCR) Reaffirms Financial Outlook for Transition Period through 2025 - GuruFocus
- 4 weeks ago - Lifecore Biomedical Inc (LFCR) Q3 2025 Earnings: EPS Loss of $0. ... - GuruFocus